The study, which will be funded by a $2.3 million grant from the U.S. Department of Defense, will harness the power of advanced MRI technology to visualize the brain in a way that has not previously been possible.  

Speaking to Vox, the authors said they were informed the results of their major study commissioned by the Department of Health and Human Services (HHS) would not be published. However, there appeared to be nothing wrong with the methodology of the analysis.

OpenAI, the developer of ChatGPT, has made a couple of big hires as it prepares for a major expansion into healthcare.

Mastering the art of effective prompts has become a coveted skill in the fast-growing field of AI. 

Experts have suggested the emerging technology could be a “pivotal” tool for the future of breast cancer detection. 

When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision. 

"This important study will evaluate the potential benefits of the AGENT DCB for patients with certain anatomical features in de novo coronary lesions, where the avoidance of stents is preferable to help circumvent potential complications,” said Janar Sathananthan, MD, chief medical officer, interventional cardiology therapies, Boston Scientific. 

New research refutes the notion that parts of the brain controlling specific extremities remap themselves following amputation, which would prevent patients from feeling pain associated with the removed appendage.